Lorraine Harper

Publications

  1. 2021
  2. E-pub ahead of print
  3. 2020
  4. Accepted/In press
  5. Accepted/In press
  6. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  7. Published

    Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis

    Lorraine Harper, Samir Mehta & Natalie Rowland, 13 Feb 2020, In: The New England Journal of Medicine. 382, 7, p. 622-631 10 p.

    Research output: Contribution to journalArticlepeer-review

  8. 2019
  9. Published
  10. E-pub ahead of print
  11. 2018
  12. Published
  13. E-pub ahead of print
  14. Published
  15. Published
  16. E-pub ahead of print
  17. Published
  18. Published
  19. 2017
  20. Published

    Avoidance of Harm From Treatment for ANCA-Associated Vasculitis

    Lorraine Harper, Dec 2017, In: Current Treatment Options in Rheumatology. 3, 4, p. 230-243 14 p.

    Research output: Contribution to journalReview articlepeer-review

  21. Published

    The European Vasculitis Society 2016 Meeting Report

    Lorraine Harper, Mark Little, Nov 2017, In: Kidney International Reports. 2, 6, p. 1018-1031

    Research output: Contribution to journalArticlepeer-review

  22. Published

    Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

    Lorraine Harper, Sep 2017, In: Journal of the American Society of Nephrology. 28, 9, p. 2756-2767 12 p., 28400446.

    Research output: Contribution to journalArticlepeer-review

  23. Published
  24. Published
  25. 2016
  26. Published
  27. Published
  28. Published
  29. E-pub ahead of print
  30. 2015
  31. Published
  32. Published

    Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab

    Matthew Morgan, Lorraine Harper, Jul 2015, In: American Journal of Nephrology. 41, 4-5, p. 296-301 6 p.

    Research output: Contribution to journalArticlepeer-review

  33. Published
  34. Published

    Rituximab for treatment of severe renal disease in ANCA associated vasculitis

    Matthew Morgan, Lorraine Harper, 19 May 2015, In: Journal of nephrology.

    Research output: Contribution to journalArticlepeer-review

  35. Published
  36. Published
  37. Published

    Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis

    Lorraine Harper & Mark Little, Apr 2015, In: Nephrology, Dialysis, Transplantation. 30 Suppl 1, p. i164-70

    Research output: Contribution to journalArticlepeer-review

  38. Published
  39. Published
  40. Published
  41. Published
  42. Published
  43. 2014
  44. Published

    BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

    David Carruthers, Lorraine Harper, Dec 2014, In: Rheumatology (Oxford). 53, 12, p. 2306-2309 4 p.

    Research output: Contribution to journalArticle

  45. Published

    Genetics of toll like receptor 9 in ANCA associated vasculitides

    Lorraine Harper, 1 May 2014, In: Annals of the Rheumatic Diseases. 73, 5, p. 890-896 7 p.

    Research output: Contribution to journalArticlepeer-review

  46. Published

    Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis

    Lorraine Harper, Mark Little, May 2014, In: Rheumatology (Oxford). 53, 5, p. 953-6 4 p.

    Research output: Contribution to journalArticlepeer-review

  47. Published
  48. Published

    The characterisation and determinants of quality of life in ANCA associated vasculitis

    Lorraine Harper, Mark Little, Jan 2014, In: Annals of the Rheumatic Diseases. 73, 1, p. 207-11 5 p.

    Research output: Contribution to journalArticlepeer-review

  49. Published
  50. 2013
  51. Published

    Predictors and consequences of fatigue in prevalent kidney transplant recipients

    Jos Bosch, David Jones, Nicholas Inston, Philip McTernan, Lorraine Harper, 15 Dec 2013, In: Transplantation. 96, 11, p. 987-994 8 p.

    Research output: Contribution to journalArticlepeer-review

  52. Published
  53. Published

    Explaining fatigue in ANCA-associated vasculitis

    Lorraine Harper, Sep 2013, In: Rheumatology (Oxford). 52, 9, p. 1680-5 6 p.

    Research output: Contribution to journalArticlepeer-review

  54. Published

    Cardiovascular Effects of Sevelamer in Stage 3 CKD

    Colin Chue, Jon Townend, William Moody, Lorraine Harper, Nicky Edwards, Apr 2013, In: Journal of the American Society of Nephrology. 24, 5, p. 842-52 11 p.

    Research output: Contribution to journalArticlepeer-review

  55. Published

    L42. Morbidity in patients with ANCA-associated vasculitis

    Lorraine Harper, Apr 2013, In: La Presse Medicale. 42, 4 Pt 2, p. 612-6 5 p.

    Research output: Contribution to journalArticle

  56. Published
  57. Published
  58. Published
  59. 2012
  60. Published
Previous 1 2 3 Next